Epivir-HBV, the first oral drug for chronic hepatitis B

November 1998

The FDA will soon approve Epivir-HBV, the first oral drug for chronic hepatitis B.

Epivir-HBV contains lamivudine...the same antiviral that's in Epivir tabs for HIV.

The difference is the dose.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote